-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The net result for the period of deducting operating expenses from operating revenues.
-
Summary
-
Akoya Biosciences, Inc. quarterly/annual Operating Income (Loss) history and growth rate from Q1 2020 to Q1 2025.
- Akoya Biosciences, Inc. Operating Income (Loss) for the quarter ending March 31, 2025 was -$13.4M, a 37.9% increase year-over-year.
- Akoya Biosciences, Inc. Operating Income (Loss) for the twelve months ending March 31, 2025 was -$38.6M, a 37.6% increase year-over-year.
- Akoya Biosciences, Inc. annual Operating Income (Loss) for 2024 was -$46.7M, a 19% increase from 2023.
- Akoya Biosciences, Inc. annual Operating Income (Loss) for 2023 was -$57.7M, a 12.8% increase from 2022.
- Akoya Biosciences, Inc. annual Operating Income (Loss) for 2022 was -$66.1M, a 68.2% decline from 2021.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Quarterly (USD)
Operating Income (Loss), YoY Quarterly Growth (%)
Operating Income (Loss), Annual (USD)
Operating Income (Loss), YoY Annual Growth (%)